Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesASP Isotopes Inc. Common Stock

ASP Isotopes Inc. Common Stock

Basic Materials Chemicals
PortfolioPortfolio WatchlistWatchlist
Company price
2.125 USD 0.05 ( 2.41%)
Last update at 2026-11-09T15:10:00Z
VOLUME
546394
Market Cap
637.07M

Momentum Score

…

ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs. The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry. In addition, the company develops Zinc-68, Nickel-64, and Xenon-129/136 for the nuclear medical industry; Lithium-7, Uranium-235, and Chlorine-37 for the energy industry; and Germanium-70/72/74 for semiconductor markets. The company was incorporated in 2021 and is based in Dallas, Texas.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
2.02
Low
2.12
High
52 Week Price Range
3.92
Low
14.49
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public disclosures on ASP Isotopes Inc. are limited and restrict detailed analysis; the company is listed on NASDAQ under ASPI. Available information indicates involvement in isotope production for medical and industrial uses, where long-term growth drivers may include rising demand for diagnostic and therapeutic isotopes, persistent sector supply shortages, and potential upside from capacity expansion and regulatory approvals that could support recurring contracts.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
2.08
Dividend Yield
-
Revenue TTM
23.85M
Revenue Per Share
0.29
Gross Profit TTM
3.40M
Debt / Equity
1.06
ROE
-101.79%
Net Debt
-69.60M
ROCE
-33.11%
Diluted EPS TTM
-2.11

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -159.56M -32.31M -16.30M -4.95M -
Minority interest -15.25M 0.09M 0.01M - -
Net income -175.09M -32.33M -16.29M -4.79M -
Selling general administrative 48.24M 24.81M 15.42M 3.83M -
Gross profit 3.40M 1.60M 0.14M - -
Reconciled depreciation 1.91M 0.47M 0.04M - -
Ebit -158.99M -32.05M -16.18M -5.10M -7.82M
Ebitda -157.07M -31.58M -16.14M -5.25M -
Depreciation and amortization 1.91M 0.47M 0.04M -0.15M -
Operating income -57.19M -26.35M -16.04M -5.10M -
Other operating expenses 81.04M 30.50M 16.48M 5.10M -
Interest expense 0.57M 0.26M 0.12M 0.15M -
Tax provision 0.28M 0.11M -0.01M - -
Interest income 6.79M 1.24M 0.01M 0.00M -
Net interest income 6.21M 0.98M 0.01M 0.00M -
Income tax expense 0.28M 0.11M -0.01M -0.15M -
Total revenue 23.85M 4.14M 0.43M 0.00M -
Total operating expenses 60.60M 27.95M 16.18M 5.10M -
Cost of revenue 20.44M 2.54M 0.29M - -
Total other income expense net -102.37M -5.96M -0.26M 0.15M -
Net income from continuing ops -159.84M -32.42M -13.43M -4.95M -
Net income applicable to common shares - - - - -7.82M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 512.88M 94.35M 30.19M 12.50M 7.14M
Intangible assets 1.48M 3168097.83M 3267099.73M - -
Other current assets 4.62M 3.05M 1.66M 0.91M 0.27M
Total liab 249.98M 43.18M 11.36M 2.68M 1.14M
Total stockholder equity 204.15M 47.90M 16.30M 9.82M 6.00M
Other current liab 12.42M 3.53M 2.81M 0.50M 0.12M
Common stock 1.12M 0.72M 0.49M 0.36M 0.21M
Capital stock 1.12M 0.72M 0.49M 0.36M 0.21M
Retained earnings -231.26M -56.17M -23.84M -7.55M -2.61M
Good will 8.57M 3.17M 3.27M - -
Other assets - -0.29M 0.00M 0.14M -
Cash 285.56M 61.89M 7.91M 2.39M 2.95M
Total current liabilities 32.70M 7.06M 5.67M 1.94M 0.30M
Current deferred revenue 0.88M 0.88M 0.88M - 0.04M
Net debt -69.60M -24.14M -5.77M -1.57M -2.03M
Short term debt 13.64M 1.62M 0.87M 0.08M 0.08M
Short long term debt 12.88M 0.94M 0.47M 0.03M 0.05M
Short long term debt total 215.96M 37.75M 2.14M 0.82M 0.93M
Other stockholder equity 431.76M 105.52M 40.57M 16.76M 8.38M
Property plant equipment - - - - 3.92M
Total current assets 398.14M 65.74M 10.51M 3.30M 3.22M
Long term investments 47.31M 0.00M - - -
Net tangible assets - - - 9.82M 6.00M
Short term investments 47.74M - - - -
Net receivables 51.71M 0.73M 0.94M - -
Long term debt 200.79M 34.87M - - -
Inventory 8.49M 0.07M - - -
Accounts payable 5.75M 1.02M 1.11M 1.35M 0.06M
Accumulated other comprehensive income 2.54M -2.16M -0.92M 0.26M 0.02M
Non currrent assets other 5.87M -3.81M 3267101.53M 0.14M -
Non current assets total 114.74M 28.60M 19.68M 9.19M 3.92M
Capital lease obligations 2.28M 1.93M 1.67M 0.79M 0.88M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -47.74M -11.37M -2.09M -4.47M -
Change to liabilities - - - 0.00M 0.18M
Total cashflows from investing activities -90.00M -11.37M -2.45M - -8.96M
Net borrowings 41.54M 25.72M -0.18M - 0.14M
Total cash from financing activities 350.80M 82.53M 13.39M 6.64M 19.50M
Change to operating activities - - - -0.54M -0.89M
Net income -175.09M -32.33M -16.29M -4.95M -7.82M
Change in cash 223.67M 54.47M 5.52M -0.56M 8.86M
Begin period cash flow 61.89M 7.91M 2.39M 2.95M -
End period cash flow 285.56M 61.89M 7.91M 2.39M 2.95M
Total cash from operating activities -37.78M -16.70M -5.41M -2.94M -1.73M
Issuance of capital stock 320.30M 53.09M 10.00M 8.12M -
Depreciation 1.91M 0.47M 0.04M 0.07M 0.06M
Other cashflows from investing activities -29.97M -1.70M - - -
Dividends paid - 2.78M - - -
Change to inventory -0.32M -0.07M 0.22M - -
Change to account receivables -0.45M -0.51M 0.24M - -
Other cashflows from financing activities -0.40M 2.78M -0.56M -1.47M -0.68M
Change to netincome - - - 1.90M 6.75M
Capital expenditures 9.65M 11.37M 2.33M 4.47M 8.96M
Change in working capital -3.63M -2.62M 1.16M 0.03M -
Stock based compensation 16.02M 8.56M 8.74M 2.00M -
Other non cash items 139.07M 2.41M 0.92M -0.03M -
Free cash flow -47.43M -28.07M -7.74M -7.41M -

Peer Comparison*

Sector: Basic Materials Industry: Chemicals

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
ASPI
ASP Isotopes Inc. Common Stock		 0.05
2.41%		 2.12 - 54.35 26.71 3.37 23.96 -12.17
SHECF
Shin-Etsu Chemical Co. Ltd		 -0.30
0.88%		 33.86 23.22 18.73 0.03 2.38 3.50 9.45
SHECY
Shin-Etsu Chemical Co Ltd ADR		 0.58
3.42%		 17.52 22.65 18.25 0.03 2.32 3.46 9.34
BFFAF
BASF SE NA O.N.		 -4.03
6.37%		 59.20 33.31 25.58 0.93 1.43 1.13 8.85
BASFY
BASF SE ADR		 -
-%		 15.13 33.15 25.25 0.93 1.41 1.13 8.85

Profile*

ASP Isotopes Inc. Common Stock

ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs. The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry. In addition, the company develops Zinc-68, Nickel-64, and Xenon-129/136 for the nuclear medical industry; Lithium-7, Uranium-235, and Chlorine-37 for the energy industry; and Germanium-70/72/74 for semiconductor markets. The company was incorporated in 2021 and is based in Dallas, Texas.

2200 Ross Avenue, Dallas, TX, United States, 75201

(214) 432-8219

https://aspisotopes.com

271

Name Title Year Born
Mr. Paul Elliot Mann CEO & Chairman 1976
Mr. Robert Ainscow Interim Chief Financial Officer 1976
Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. Chief Technology Officer & Director 1960
Mr. Paul Elliot Mann President, CEO & Executive Chairman 1977
Mr. Robert Ainscow CFO & COO 1977
Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. CTO & Director 1961
Mr. Paul Elliot Mann C.F.A. President, CEO & Executive Chairman 1976
Mr. Robert Ainscow Chief Operating Officer 1976
Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. CTO & Director 1960
Ms. Heather Kiessling Chief Financial Officer 1964

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

GFR
CAD 10.93
+37.83%
MOON
CAD 4.86
+10.20%
HG
CAD 4.43
+9.93%
EPRX
CAD 10.57
+8.86%
NUAG
CAD 8.66
+8.79%
CSU
CAD 3257.60
-7.63%
DIV
CAD 3.85
-5.53%
TOI
CAD 99.00
-5.52%
BSX
CAD 0.82
-4.65%
LMN
CAD 26.79
-4.63%

Equity Sectors*

  • Basic Materials

    +3.88%

  • Communication Services

    -1.14%

  • Consumer Cyclical

    +0.75%

  • Consumer Defensive

    -0.36%

  • Energy

    +2.16%

  • Financial Services

    +1.33%

  • Healthcare

    +1.50%

  • Industrials

    +2.97%

  • Real Estate

    +0.41%

  • Technology

    +1.27%

  • Utilities

    +1.09%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…